About AST

Transplant News

May, 2014

May 08, 2014
The AST has been working closely with the office of Congressman Jim Renacci (R-OH) to garner support for his legislation (HR 4188) that seeks to exempt organ transplantation, ESRD, and other targeted conditions from classification as an admission for purposes of penalties under the Affordable Care Act (ACA). AST believes this legislative proposal is an essential and necessary step for protecting certain patient populations that would otherwise be compromised under the current law policy for hospital readmissions. The Society is working to garner cosponsors, support from Leadership in the... Read More...

March, 2014

March 27, 2014
Stephen Harms has been selected as Chief Operating Officer of the United Network for Organ Sharing (UNOS). As COO, Mr. Harms will oversee key projects that promote UNOS' strategic plan. He'll report to the Chief Executive Officer and assist in developing, planning, and implementing strategic objectives to drive successful growth. Mr. Harms served nearly 30 years in legislative and executive capacities for the Commonwealth of Virginia. He served in cabinet-level positions for Virginia Governors Mark Warner and Tim Kaine, in roles including Deputy Chief of Staff, Deputy Secretary of Finance... Read More...
March 13, 2014
U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH NIH News Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) http://www.nichd.nih.gov Embargoed for Release: Thursday, March 13, 2014 CONTACT: Robert Bock, 301-496-5134 e-mail:bockr@mail.nih.gov Kerri Childress, 301-496-5133 e-mail:Kerri.Childress@nih.gov NIH OPENS RESEARCH HOSPITAL TO OUTSIDE SCIENTISTS New program tackles disease on many fronts Ten projects... Read More...
March 11, 2014
The Transplant Roundtable, a coalition of organ transplant patients, health professionals, and related organizations dedicated to preserving transplant patients' access to optimal care, recently provided comments to the Centers for Medicare and Medicaid Services (CMS) Medicare Program; Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs (the "Proposed Rule"). The Proposed Rule would enable Part D sponsors to impose formulary restrictions on immunosuppressive drugs, resulting in substantial risk of organ rejection,... Read More...
March 10, 2014
Earlier today, the Obama Administration informed top congressional leaders that it will not finalize any of the changes it had proposed to the Six Protected Classes Policy in the Jan. 10 regulation... including the proposed removal of transplant immuno drugs from the protected class category. They note the considerable pushback received on this and some other aspects of the rule during the comment period. It was also pointed out, that the issues may be revisited in future years. As you know, AST submitted official comments opposing the rule to CMS. The AST was mentioned by name at the recent... Read More...
March 06, 2014
A video podcast developed by OPTN and UNOS entitled "The New Kidney Allocation System: What Referring Physicians Need to Know” is now available on the OPTN and Transplant Pro websites.  View the video on the OPTN website View the video on the UNIOS Transplant Pro website Download the slides here to follow along with the... Read More...
March 03, 2014
UNOS welcomes applications for a Chief Medical Officer (CMO), an executive-level position reporting to UNOS’ Chief Executive Officer. As a member of the UNOS senior staff, the CMO serves as an expert medical and clinical resource to other UNOS staff, committee members, the government, and the general public in the performance of OPTN contract requirements and other UNOS corporate initiatives. He or she will provide advice with respect to the medical and clinical aspects of OPTN operations, including participation in OPTN policy development, policy compliance, patient safety-related incident... Read More...

February, 2014

February 26, 2014
The American Society of Transplantation has serious concerns regarding the proposed rule to remove immunosuppressant medications for transplant rejection prophylaxis as a protected class under Medicare Parts C and D. To view the full statement please follow the link below: AST Statement Regarding Transplant community opposition to CMS proposal to remove Immunosuppressive medications from Medicare Part D Protected Class category  
February 26, 2014
The American Society of Transplantation (AST) Raises Concerns about Plans to Limit Medicare Drug Coverage; Calls Potential Changes “Life-Threatening” AST strongly opposes the CMS proposed rule to remove immunosuppressant medications as a protected class under Medicare Parts C and D WASHINGTON, DC – February 26, 2014 – The American Society of Transplantation (AST), representing the majority of professionals engaged in the field of organ transplantation, today expressed their concern about the Centers for Medicare & Medicaid Services (CMS) proposed rule to eliminate immunosuppressive... Read More...

Pages